| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | acetylcholine receptor regulator activity | SPDYE1 SPDYE11 SPDYE7P SPDYE3 SPDYE2 SPDYE5 SPDYE2B SPDYE4 SPDYE6 SPDYE16 | 8.99e-18 | 27 | 85 | 10 | GO:0030548 |
| GeneOntologyMolecularFunction | neurotransmitter receptor regulator activity | SPDYE1 SPDYE11 SPDYE7P SPDYE3 SPDYE2 SPDYE5 SPDYE2B SPDYE4 SPDYE6 SPDYE16 | 1.39e-17 | 28 | 85 | 10 | GO:0099602 |
| GeneOntologyMolecularFunction | protein kinase binding | SPDYE1 SPDYE11 SPDYE17 SPDYE10 BRAF SPDYE15 SPDYE7P SPDYE3 SPDYE2 SPDYE8 GRIA1 SPDYE21 SPDYE5 SPDYE18 RAPGEF2 SPDYE12 SPDYE2B SPDYE4 RAB13 SPDYE6 ADD2 SPDYE14 SPDYE16 | 1.08e-12 | 873 | 85 | 23 | GO:0019901 |
| GeneOntologyMolecularFunction | kinase binding | PRPSAP1 SPDYE1 SPDYE11 SPDYE17 SPDYE10 BRAF SPDYE15 SPDYE7P SPDYE3 SPDYE2 SPDYE8 GRIA1 SPDYE21 SPDYE5 SPDYE18 RAPGEF2 SPDYE12 SPDYE2B SPDYE4 RAB13 SPDYE6 ADD2 SPDYE14 SPDYE16 | 1.16e-12 | 969 | 85 | 24 | GO:0019900 |
| GeneOntologyMolecularFunction | signaling receptor regulator activity | SPDYE1 SPDYE11 SPDYE7P SPDYE3 SPDYE2 SPDYE5 SPDYE2B SPDYE4 DKK2 SPDYE6 SPDYE16 | 5.93e-05 | 616 | 85 | 11 | GO:0030545 |
| GeneOntologyMolecularFunction | ribose phosphate diphosphokinase activity | 1.78e-04 | 5 | 85 | 2 | GO:0004749 | |
| GeneOntologyMolecularFunction | diphosphotransferase activity | 2.66e-04 | 6 | 85 | 2 | GO:0016778 | |
| GeneOntologyBiologicalProcess | positive regulation of cyclin-dependent protein serine/threonine kinase activity | SPDYE1 SPDYE7P SPDYE3 SPDYE2 SPDYE5 SPDYE2B SPDYE4 SPDYE6 SPDYE16 | 1.49e-16 | 25 | 76 | 9 | GO:0045737 |
| GeneOntologyBiologicalProcess | positive regulation of cyclin-dependent protein kinase activity | SPDYE1 SPDYE7P SPDYE3 SPDYE2 SPDYE5 SPDYE2B SPDYE4 SPDYE6 SPDYE16 | 5.01e-16 | 28 | 76 | 9 | GO:1904031 |
| GeneOntologyBiologicalProcess | regulation of cyclin-dependent protein serine/threonine kinase activity | SPDYE1 GTPBP4 SPDYE7P SPDYE3 SPDYE2 SPDYE5 SPDYE2B SPDYE4 NR2F2 SPDYE6 SPDYE16 | 5.50e-14 | 96 | 76 | 11 | GO:0000079 |
| GeneOntologyBiologicalProcess | regulation of cyclin-dependent protein kinase activity | SPDYE1 GTPBP4 SPDYE7P SPDYE3 SPDYE2 SPDYE5 SPDYE2B SPDYE4 NR2F2 SPDYE6 SPDYE16 | 8.73e-14 | 100 | 76 | 11 | GO:1904029 |
| GeneOntologyBiologicalProcess | positive regulation of protein serine/threonine kinase activity | SPDYE1 SPDYE7P SPDYE3 SPDYE2 SPDYE5 RAPGEF2 SPDYE2B SPDYE4 SPDYE6 SPDYE16 | 2.28e-09 | 193 | 76 | 10 | GO:0071902 |
| GeneOntologyBiologicalProcess | regulation of protein serine/threonine kinase activity | SPDYE1 GTPBP4 SPDYE7P SPDYE3 SPDYE2 SPDYE5 RAPGEF2 SPDYE2B SPDYE4 NR2F2 SPDYE6 SPDYE16 | 7.12e-09 | 358 | 76 | 12 | GO:0071900 |
| GeneOntologyBiologicalProcess | regulation of protein kinase activity | SPDYE1 GTPBP4 SPDYE7P TSPYL2 SPDYE3 SPDYE2 SPDYE5 RAPGEF2 SPDYE2B SPDYE4 NR2F2 SPDYE6 SPDYE16 | 3.28e-07 | 611 | 76 | 13 | GO:0045859 |
| GeneOntologyBiologicalProcess | positive regulation of protein kinase activity | SPDYE1 SPDYE7P SPDYE3 SPDYE2 SPDYE5 RAPGEF2 SPDYE2B SPDYE4 SPDYE6 SPDYE16 | 6.15e-07 | 350 | 76 | 10 | GO:0045860 |
| GeneOntologyBiologicalProcess | regulation of kinase activity | SPDYE1 GTPBP4 SPDYE7P TSPYL2 SPDYE3 SPDYE2 SPDYE5 RAPGEF2 SPDYE2B SPDYE4 NR2F2 SPDYE6 SPDYE16 | 1.21e-06 | 686 | 76 | 13 | GO:0043549 |
| GeneOntologyBiologicalProcess | regulation of transferase activity | SPDYE1 GTPBP4 SPDYE7P TSPYL2 SPDYE3 SPDYE2 PUM3 SPDYE5 RAPGEF2 SPDYE2B SPDYE4 NR2F2 SPDYE6 SPDYE16 | 1.33e-06 | 810 | 76 | 14 | GO:0051338 |
| GeneOntologyBiologicalProcess | positive regulation of kinase activity | SPDYE1 SPDYE7P SPDYE3 SPDYE2 SPDYE5 RAPGEF2 SPDYE2B SPDYE4 SPDYE6 SPDYE16 | 2.29e-06 | 405 | 76 | 10 | GO:0033674 |
| GeneOntologyBiologicalProcess | positive regulation of cell cycle | SPDYE1 SPDYE7P ASNS SPDYE3 SPDYE2 SPDYE5 SPDYE2B SPDYE4 SPDYE6 SPDYE16 | 2.40e-06 | 407 | 76 | 10 | GO:0045787 |
| GeneOntologyBiologicalProcess | positive regulation of transferase activity | SPDYE1 SPDYE7P SPDYE3 SPDYE2 SPDYE5 RAPGEF2 SPDYE2B SPDYE4 SPDYE6 SPDYE16 | 1.23e-05 | 490 | 76 | 10 | GO:0051347 |
| GeneOntologyBiologicalProcess | positive regulation of protein phosphorylation | FNIP2 SPDYE1 BRAF SPDYE7P SPDYE3 SPDYE2 SPDYE5 RAPGEF2 SPDYE2B SPDYE4 SPDYE6 SPDYE16 | 1.26e-05 | 724 | 76 | 12 | GO:0001934 |
| GeneOntologyBiologicalProcess | regulation of protein phosphorylation | FNIP2 SPDYE1 GTPBP4 BRAF SPDYE7P TSPYL2 SPDYE3 SPDYE2 SPDYE5 RAPGEF2 SPDYE2B SPDYE4 NR2F2 SPDYE6 SPDYE16 | 1.37e-05 | 1133 | 76 | 15 | GO:0001932 |
| GeneOntologyBiologicalProcess | positive regulation of phosphorylation | FNIP2 SPDYE1 BRAF SPDYE7P SPDYE3 SPDYE2 SPDYE5 RAPGEF2 SPDYE2B SPDYE4 SPDYE6 SPDYE16 | 2.64e-05 | 780 | 76 | 12 | GO:0042327 |
| GeneOntologyBiologicalProcess | regulation of phosphorylation | FNIP2 SPDYE1 GTPBP4 BRAF SPDYE7P TSPYL2 SPDYE3 SPDYE2 SPDYE5 RAPGEF2 SPDYE2B SPDYE4 NR2F2 SPDYE6 SPDYE16 | 3.45e-05 | 1226 | 76 | 15 | GO:0042325 |
| GeneOntologyBiologicalProcess | regulation of cell cycle | SPDYE1 GTPBP4 CCNDBP1 SPDYE7P MAEA ASNS TSPYL2 SPDYE3 SPDYE2 SPDYE5 SPDYE2B SPDYE4 NR2F2 SPDYE6 SPDYE16 | 4.56e-05 | 1256 | 76 | 15 | GO:0051726 |
| GeneOntologyBiologicalProcess | positive regulation of phosphate metabolic process | FNIP2 SPDYE1 BRAF SPDYE7P SPDYE3 SPDYE2 SPDYE5 RAPGEF2 SPDYE2B SPDYE4 SPDYE6 SPDYE16 | 8.37e-05 | 879 | 76 | 12 | GO:0045937 |
| GeneOntologyBiologicalProcess | positive regulation of phosphorus metabolic process | FNIP2 SPDYE1 BRAF SPDYE7P SPDYE3 SPDYE2 SPDYE5 RAPGEF2 SPDYE2B SPDYE4 SPDYE6 SPDYE16 | 8.37e-05 | 879 | 76 | 12 | GO:0010562 |
| GeneOntologyBiologicalProcess | positive regulation of protein modification process | FNIP2 SPDYE1 BRAF SPDYE7P SPDYE3 SPDYE2 SPDYE5 RAPGEF2 SPDYE2B SPDYE4 SPDYE6 SPDYE16 | 1.53e-04 | 937 | 76 | 12 | GO:0031401 |
| GeneOntologyBiologicalProcess | regulation of phosphate metabolic process | FNIP2 SPDYE1 GTPBP4 BRAF SPDYE7P TSPYL2 SPDYE3 SPDYE2 SPDYE5 RAPGEF2 SPDYE2B SPDYE4 NR2F2 SPDYE6 SPDYE16 | 1.82e-04 | 1421 | 76 | 15 | GO:0019220 |
| GeneOntologyBiologicalProcess | regulation of phosphorus metabolic process | FNIP2 SPDYE1 GTPBP4 BRAF SPDYE7P TSPYL2 SPDYE3 SPDYE2 SPDYE5 RAPGEF2 SPDYE2B SPDYE4 NR2F2 SPDYE6 SPDYE16 | 1.85e-04 | 1423 | 76 | 15 | GO:0051174 |
| GeneOntologyBiologicalProcess | 5-phosphoribose 1-diphosphate biosynthetic process | 1.99e-04 | 6 | 76 | 2 | GO:0006015 | |
| GeneOntologyBiologicalProcess | 5-phosphoribose 1-diphosphate metabolic process | 1.99e-04 | 6 | 76 | 2 | GO:0046391 | |
| GeneOntologyBiologicalProcess | regulation of protein modification process | FNIP2 SPDYE1 GTPBP4 BRAF SPDYE7P TSPYL2 SPDYE3 SPDYE2 SPDYE5 RAPGEF2 SPDYE2B SPDYE4 NR2F2 SPDYE6 SPDYE16 | 3.00e-04 | 1488 | 76 | 15 | GO:0031399 |
| GeneOntologyBiologicalProcess | response to purine-containing compound | 3.70e-04 | 166 | 76 | 5 | GO:0014074 | |
| GeneOntologyBiologicalProcess | inhibition of non-skeletal tissue mineralization | 5.92e-04 | 10 | 76 | 2 | GO:0140928 | |
| GeneOntologyBiologicalProcess | regulation of calcium ion-dependent exocytosis | 6.10e-04 | 45 | 76 | 3 | GO:0017158 | |
| GeneOntologyCellularComponent | ATF4-CREB1 transcription factor complex | 7.79e-05 | 4 | 76 | 2 | GO:1990589 | |
| GeneOntologyCellularComponent | ribose phosphate diphosphokinase complex | 1.30e-04 | 5 | 76 | 2 | GO:0002189 | |
| Domain | Spy1 | SPDYE1 SPDYE3 SPDYE2 SPDYE21 SPDYE5 SPDYE2B SPDYE4 SPDYE6 SPDYE16 | 7.94e-21 | 11 | 74 | 9 | PF11357 |
| Domain | Speedy | SPDYE1 SPDYE3 SPDYE2 SPDYE21 SPDYE5 SPDYE2B SPDYE4 SPDYE6 SPDYE16 | 7.94e-21 | 11 | 74 | 9 | IPR020984 |
| Domain | COUP_TF | 5.94e-07 | 5 | 74 | 3 | IPR003068 | |
| Domain | KID | 4.63e-05 | 3 | 74 | 2 | PS50953 | |
| Domain | Coactivator_CBP_pKID | 4.63e-05 | 3 | 74 | 2 | IPR003102 | |
| Domain | pKID | 4.63e-05 | 3 | 74 | 2 | PF02173 | |
| Domain | Leuzip_CREB | 9.24e-05 | 4 | 74 | 2 | IPR001630 | |
| Domain | Rib-P_diPkinase | 1.54e-04 | 5 | 74 | 2 | IPR005946 | |
| Domain | Pribosyltran_N | 1.54e-04 | 5 | 74 | 2 | IPR029099 | |
| Domain | Pribosyltran_N | 1.54e-04 | 5 | 74 | 2 | PF13793 | |
| Domain | Pribosyl_synth | 1.54e-04 | 5 | 74 | 2 | PF14572 | |
| Domain | zf-C4 | 8.02e-04 | 46 | 74 | 3 | PF00105 | |
| Domain | Znf_hrmn_rcpt | 8.02e-04 | 46 | 74 | 3 | IPR001628 | |
| Domain | Nuclear_hrmn_rcpt | 8.02e-04 | 46 | 74 | 3 | IPR001723 | |
| Domain | NUCLEAR_REC_DBD_2 | 8.02e-04 | 46 | 74 | 3 | PS51030 | |
| Domain | NUCLEAR_REC_DBD_1 | 8.02e-04 | 46 | 74 | 3 | PS00031 | |
| Domain | ZnF_C4 | 8.02e-04 | 46 | 74 | 3 | SM00399 | |
| Domain | Pribosyltran | 8.32e-04 | 11 | 74 | 2 | PF00156 | |
| Domain | - | 8.54e-04 | 47 | 74 | 3 | 1.10.565.10 | |
| Domain | HOLI | 9.09e-04 | 48 | 74 | 3 | SM00430 | |
| Domain | Nucl_hrmn_rcpt_lig-bd | 9.09e-04 | 48 | 74 | 3 | IPR000536 | |
| Domain | Hormone_recep | 9.09e-04 | 48 | 74 | 3 | PF00104 | |
| Domain | PRTase-like | 9.96e-04 | 12 | 74 | 2 | IPR029057 | |
| Domain | PRibTrfase_dom | 9.96e-04 | 12 | 74 | 2 | IPR000836 | |
| Domain | - | 9.96e-04 | 12 | 74 | 2 | 3.40.50.2020 | |
| Domain | - | 1.50e-03 | 57 | 74 | 3 | 3.30.50.10 | |
| Domain | Znf_NHR/GATA | 1.58e-03 | 58 | 74 | 3 | IPR013088 | |
| Domain | RasGEFN | 2.81e-03 | 20 | 74 | 2 | SM00229 | |
| Domain | Synaptotagmin | 2.81e-03 | 20 | 74 | 2 | IPR001565 | |
| Domain | RasGEF_N | 3.10e-03 | 21 | 74 | 2 | PF00618 | |
| Domain | Ras-like_Gua-exchang_fac_N | 3.40e-03 | 22 | 74 | 2 | IPR000651 | |
| Domain | RASGEF_NTER | 3.40e-03 | 22 | 74 | 2 | PS50212 | |
| Domain | cEGF | 4.73e-03 | 26 | 74 | 2 | IPR026823 | |
| Domain | cEGF | 4.73e-03 | 26 | 74 | 2 | PF12662 | |
| Domain | RASGEF_CAT | 5.87e-03 | 29 | 74 | 2 | PS50009 | |
| Domain | RasGEF | 6.27e-03 | 30 | 74 | 2 | PF00617 | |
| Domain | - | 6.27e-03 | 30 | 74 | 2 | 1.10.840.10 | |
| Domain | Ras_GEF_dom | 6.27e-03 | 30 | 74 | 2 | IPR023578 | |
| Domain | RASGEF_cat_dom | 6.27e-03 | 30 | 74 | 2 | IPR001895 | |
| Domain | RasGEF | 6.27e-03 | 30 | 74 | 2 | SM00147 | |
| Pathway | REACTOME_SIGNALING_BY_NTRK1_TRKA | 2.49e-06 | 63 | 49 | 5 | MM14714 | |
| Pathway | REACTOME_SIGNALING_BY_NTRKS | 5.92e-06 | 75 | 49 | 5 | MM14652 | |
| Pathway | WP_SEROTONIN_RECEPTOR_467_AND_NR3C_SIGNALING | 3.68e-05 | 19 | 49 | 3 | M39358 | |
| Pathway | WP_MECHANISMS_ASSOCIATED_WITH_PLURIPOTENCY | 7.51e-05 | 301 | 49 | 7 | MM15983 | |
| Pathway | REACTOME_SIGNALING_BY_NTRKS | 9.82e-05 | 134 | 49 | 5 | M3574 | |
| Pathway | REACTOME_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION | 1.09e-04 | 27 | 49 | 3 | MM14779 | |
| Pathway | WP_ESTROGEN_SIGNALING | 1.45e-04 | 77 | 49 | 4 | MM15934 | |
| Pathway | WP_PILOCYTIC_ASTROCYTOMA | 1.76e-04 | 6 | 49 | 2 | M39584 | |
| Pathway | REACTOME_NGF_STIMULATED_TRANSCRIPTION | 1.76e-04 | 6 | 49 | 2 | MM15627 | |
| Pathway | WP_BDNFTRKB_SIGNALING | 2.00e-04 | 33 | 49 | 3 | M39532 | |
| Pathway | BIOCARTA_HBX_PATHWAY | 2.46e-04 | 7 | 49 | 2 | M22037 | |
| Pathway | BIOCARTA_HBX_PATHWAY | 2.46e-04 | 7 | 49 | 2 | MM1557 | |
| Pathway | REACTOME_CREB_PHOSPHORYLATION | 2.46e-04 | 7 | 49 | 2 | M27096 | |
| Pathway | REACTOME_CREB_PHOSPHORYLATION | 2.46e-04 | 7 | 49 | 2 | MM14784 | |
| Pathway | WP_NUCLEAR_RECEPTORS | 3.06e-04 | 38 | 49 | 3 | M39657 | |
| Pathway | WP_NUCLEAR_RECEPTORS | 3.06e-04 | 38 | 49 | 3 | MM15865 | |
| Pathway | REACTOME_NGF_STIMULATED_TRANSCRIPTION | 3.30e-04 | 39 | 49 | 3 | M29793 | |
| Pathway | PID_ERBB1_DOWNSTREAM_PATHWAY | 4.76e-04 | 105 | 49 | 4 | M164 | |
| Pathway | KEGG_ENDOMETRIAL_CANCER | 7.74e-04 | 52 | 49 | 3 | M19877 | |
| Pathway | WP_FRAGILE_X_SYNDROME | 8.12e-04 | 121 | 49 | 4 | M39804 | |
| Pathway | KEGG_MEDICUS_VARIANT_BCR_ABL_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 1.05e-03 | 14 | 49 | 2 | M47364 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KIT_TO_RAS_ERK_SIGNALING_PATHWAY | 1.05e-03 | 14 | 49 | 2 | M47365 | |
| Pathway | KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_RAS_ERK_SIGNALING_PATHWAY | 1.05e-03 | 14 | 49 | 2 | M47366 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_RAS_ERK_SIGNALING_PATHWAY | 1.05e-03 | 14 | 49 | 2 | M47378 | |
| Pathway | KEGG_MEDICUS_VARIANT_MET_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY | 1.05e-03 | 14 | 49 | 2 | M47488 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_MET_TO_RAS_ERK_SIGNALING_PATHWAY | 1.21e-03 | 15 | 49 | 2 | M47367 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_RAS_ERK_SIGNALING_PATHWAY | 1.21e-03 | 15 | 49 | 2 | M47375 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_FGFR_TO_RAS_ERK_SIGNALING_PATHWAY | 1.21e-03 | 15 | 49 | 2 | M47380 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_PYK2_RAS_ERK_SIGNALING_PATHWAY | 1.21e-03 | 15 | 49 | 2 | M47592 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HBV_HBX_TO_RAS_ERK_SIGNALING_PATHWAY | 1.21e-03 | 15 | 49 | 2 | M47593 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_FGF17_TO_RAS_ERK_SIGNALING_PATHWAY | 1.21e-03 | 15 | 49 | 2 | M47640 | |
| Pathway | KEGG_MEDICUS_VARIANT_IGF2_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY | 1.21e-03 | 15 | 49 | 2 | M47485 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HGF_MET_RAS_ERK_SIGNALING_PATHWAY | 1.21e-03 | 15 | 49 | 2 | M47473 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FLT3LG_FLT3_RAS_ERK_SIGNALING_PATHWAY | 1.21e-03 | 15 | 49 | 2 | M47474 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TGFA_EGFR_RAS_ERK_SIGNALING_PATHWAY | 1.21e-03 | 15 | 49 | 2 | M47480 | |
| Pathway | KEGG_MEDICUS_VARIANT_EGF_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY | 1.21e-03 | 15 | 49 | 2 | M47495 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EREG_EGFR_RAS_ERK_SIGNALING_PATHWAY | 1.21e-03 | 15 | 49 | 2 | M47496 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AREG_EGFR_RAS_ERK_SIGNALING_PATHWAY | 1.21e-03 | 15 | 49 | 2 | M47497 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KITLG_KIT_RAS_ERK_SIGNALING_PATHWAY | 1.21e-03 | 15 | 49 | 2 | M47472 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_GB_TO_PDGFR_RAS_ERK_SIGNALING_PATHWAY | 1.21e-03 | 15 | 49 | 2 | M47535 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E5_TO_EGFR_RAS_ERK_SIGNALING_PATHWAY | 1.21e-03 | 15 | 49 | 2 | M47531 | |
| Pathway | REACTOME_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION | 1.23e-03 | 61 | 49 | 3 | M152 | |
| Pathway | WP_ENDOMETRIAL_CANCER | 1.35e-03 | 63 | 49 | 3 | M39623 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_ERK_SIGNALING_PATHWAY | 1.38e-03 | 16 | 49 | 2 | M47363 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_FGFR3_TO_RAS_ERK_SIGNALING_PATHWAY | 1.38e-03 | 16 | 49 | 2 | M47373 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_ERBB2_RAS_ERK_SIGNALING_PATHWAY | 1.38e-03 | 16 | 49 | 2 | M47381 | |
| Pathway | KEGG_MEDICUS_REFERENCE_P4_PR_RAS_ERK_SIGNALING_PATHWAY | 1.38e-03 | 16 | 49 | 2 | M47804 | |
| Pathway | WP_MAPK_PATHWAY_IN_CONGENITAL_THYROID_CANCER | 1.38e-03 | 16 | 49 | 2 | M39882 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IGF_IGF1R_RAS_ERK_SIGNALING_PATHWAY | 1.38e-03 | 16 | 49 | 2 | M47483 | |
| Pathway | REACTOME_GASTRIN_CREB_SIGNALLING_PATHWAY_VIA_PKC_AND_MAPK | 1.38e-03 | 16 | 49 | 2 | MM15477 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_RAS_ERK_SIGNALING_PATHWAY | 1.56e-03 | 17 | 49 | 2 | M47376 | |
| Pathway | WP_MELANOMA | 1.69e-03 | 68 | 49 | 3 | M39811 | |
| Pathway | REACTOME_GASTRIN_CREB_SIGNALLING_PATHWAY_VIA_PKC_AND_MAPK | 1.75e-03 | 18 | 49 | 2 | M657 | |
| Pathway | BIOCARTA_CREB_PATHWAY | 2.16e-03 | 20 | 49 | 2 | MM1520 | |
| Pathway | WP_EGFEGFR_SIGNALING | 2.38e-03 | 162 | 49 | 4 | M39334 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ACH_CHRN_RAS_ERK_SIGNALING_PATHWAY | 2.38e-03 | 21 | 49 | 2 | M47792 | |
| Pathway | BIOCARTA_CREB_PATHWAY | 2.62e-03 | 22 | 49 | 2 | M9070 | |
| Pathway | KEGG_MEDICUS_REFERENCE_E2_ER_RAS_ERK_SIGNALING_PATHWAY | 2.86e-03 | 23 | 49 | 2 | M47799 | |
| Pathway | REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION_TERMINATION | 2.86e-03 | 23 | 49 | 2 | M1024 | |
| Pathway | WP_ESTROGEN_SIGNALING | 2.86e-03 | 23 | 49 | 2 | M39672 | |
| Pubmed | Identification and comparative analysis of multiple mammalian Speedy/Ringo proteins. | SPDYE1 SPDYE17 SPDYE7P SPDYE3 SPDYE2 SPDYE5 SPDYE2B SPDYE4 SPDYE6 SPDYE16 | 1.25e-24 | 13 | 85 | 10 | 15611625 |
| Pubmed | Murine fertility and spermatogenesis are independent of the testis-specific Spdye4a gene. | SPDYE1 SPDYE7P SPDYE3 SPDYE2 SPDYE5 SPDYE2B SPDYE4 SPDYE6 SPDYE16 | 2.01e-24 | 9 | 85 | 9 | 36272447 |
| Pubmed | Characterization of a new family of cyclin-dependent kinase activators. | SPDYE1 SPDYE17 SPDYE7P SPDYE3 SPDYE2 SPDYE5 SPDYE2B SPDYE4 SPDYE6 SPDYE16 | 8.42e-23 | 17 | 85 | 10 | 15574121 |
| Pubmed | 1.41e-08 | 3 | 85 | 3 | 22763696 | ||
| Pubmed | 1.41e-08 | 3 | 85 | 3 | 18701084 | ||
| Pubmed | 2.80e-07 | 6 | 85 | 3 | 11865068 | ||
| Pubmed | 2.80e-07 | 6 | 85 | 3 | 7947324 | ||
| Pubmed | 1.17e-06 | 9 | 85 | 3 | 7823919 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 19766631 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 20945072 | ||
| Pubmed | CREB function is required for normal thymic cellularity and post-irradiation recovery. | 5.90e-06 | 2 | 85 | 2 | 15214044 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 11988175 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 28963436 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 23504989 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 7708064 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 7626501 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 8183930 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 7609634 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 2905047 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 15907456 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 19160499 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 8804707 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 16488127 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 29286077 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 17071615 | ||
| Pubmed | Established and novel Cdk/cyclin complexes regulating the cell cycle and development. | 5.90e-06 | 2 | 85 | 2 | 21630153 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 28922831 | ||
| Pubmed | 1.29e-05 | 441 | 85 | 8 | 12853948 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 19561568 | ||
| Pubmed | Vasoactive intestinal peptide upregulates MUC2 intestinal mucin via CREB/ATF1. | 1.77e-05 | 3 | 85 | 2 | 16227528 | |
| Pubmed | Tumors with EWSR1-CREB1 and EWSR1-ATF1 fusions: the current status. | 1.77e-05 | 3 | 85 | 2 | 22510762 | |
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 9671480 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 31474762 | ||
| Pubmed | CRL2ZER1/ZYG11B recognizes small N-terminal residues for degradation. | 1.77e-05 | 3 | 85 | 2 | 36496439 | |
| Pubmed | NGS testing for cardiomyopathy: Utility of adding RASopathy-associated genes. | 1.77e-05 | 3 | 85 | 2 | 29696744 | |
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 10644740 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 10722738 | ||
| Pubmed | Activating transcription factor-1 can mediate Ca(2+)- and cAMP-inducible transcriptional activation. | 1.77e-05 | 3 | 85 | 2 | 8384217 | |
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 9632703 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 12391222 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 23988737 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 25922524 | ||
| Pubmed | MSK1 is required for CREB phosphorylation in response to mitogens in mouse embryonic stem cells. | 1.77e-05 | 3 | 85 | 2 | 11018520 | |
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 10945975 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 29179997 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 15677473 | ||
| Pubmed | Regulation of renin expression by the orphan nuclear receptors Nr2f2 and Nr2f6. | 1.77e-05 | 3 | 85 | 2 | 22278040 | |
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 11382775 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 20186801 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 20536573 | ||
| Pubmed | 2.10e-05 | 22 | 85 | 3 | 23975195 | ||
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 24719331 | ||
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 1655749 | ||
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 12871976 | ||
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 18199540 | ||
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 11354513 | ||
| Pubmed | The language phenotype of children and adolescents with Noonan syndrome. | 3.53e-05 | 4 | 85 | 2 | 20543023 | |
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 11909979 | ||
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 23775080 | ||
| Pubmed | The COUP-TF nuclear receptors regulate cell migration in the mammalian basal forebrain. | 3.53e-05 | 4 | 85 | 2 | 15548577 | |
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 8798441 | ||
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 28009602 | ||
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 10744719 | ||
| Pubmed | 3.92e-05 | 77 | 85 | 4 | 19505873 | ||
| Pubmed | A role for Sp and nuclear receptor transcription factors in a cardiac hypertrophic growth program. | 5.87e-05 | 5 | 85 | 2 | 9177236 | |
| Pubmed | 5.87e-05 | 5 | 85 | 2 | 8663317 | ||
| Pubmed | Molecular basis for recognition of Gly/N-degrons by CRL2ZYG11B and CRL2ZER1. | 5.87e-05 | 5 | 85 | 2 | 34214466 | |
| Pubmed | Disruption of CREB function in brain leads to neurodegeneration. | 5.87e-05 | 5 | 85 | 2 | 11967539 | |
| Pubmed | 5.87e-05 | 5 | 85 | 2 | 10318855 | ||
| Pubmed | 8.80e-05 | 6 | 85 | 2 | 23911420 | ||
| Pubmed | 8.80e-05 | 6 | 85 | 2 | 15736129 | ||
| Pubmed | Identification of synaptotagmin effectors via acute inhibition of secretion from cracked PC12 cells. | 8.80e-05 | 6 | 85 | 2 | 12860971 | |
| Pubmed | 8.80e-05 | 6 | 85 | 2 | 15806162 | ||
| Pubmed | Spatial control of astrogenesis progression by cortical arealization genes. | 8.80e-05 | 6 | 85 | 2 | 35818636 | |
| Pubmed | 1.23e-04 | 7 | 85 | 2 | 25644539 | ||
| Pubmed | 1.23e-04 | 7 | 85 | 2 | 23241891 | ||
| Pubmed | CoupTFI interacts with retinoic acid signaling during cortical development. | 1.23e-04 | 7 | 85 | 2 | 23472160 | |
| Pubmed | 1.23e-04 | 7 | 85 | 2 | 20797425 | ||
| Pubmed | 1.23e-04 | 7 | 85 | 2 | 19535498 | ||
| Pubmed | 1.23e-04 | 7 | 85 | 2 | 19206169 | ||
| Pubmed | 1.23e-04 | 7 | 85 | 2 | 20302979 | ||
| Pubmed | Cognitive profile of disorders associated with dysregulation of the RAS/MAPK signaling cascade. | 1.23e-04 | 7 | 85 | 2 | 19133693 | |
| Pubmed | 1.64e-04 | 8 | 85 | 2 | 10567391 | ||
| Pubmed | Germline gain-of-function mutations in SOS1 cause Noonan syndrome. | 1.64e-04 | 8 | 85 | 2 | 17143285 | |
| Pubmed | 1.64e-04 | 8 | 85 | 2 | 17376811 | ||
| Pubmed | 1.64e-04 | 8 | 85 | 2 | 12015964 | ||
| Pubmed | 1.64e-04 | 8 | 85 | 2 | 32421711 | ||
| Pubmed | 2.10e-04 | 9 | 85 | 2 | 10531343 | ||
| Pubmed | Protein kinase A signalling via CREB controls myogenesis induced by Wnt proteins. | 2.10e-04 | 9 | 85 | 2 | 15568017 | |
| Pubmed | Apoptosis, axonal growth defects, and degeneration of peripheral neurons in mice lacking CREB. | 2.10e-04 | 9 | 85 | 2 | 11988169 | |
| Pubmed | Isolation, characterization, and chromosomal localization of mouse and human COUP-TF I and II genes. | 2.10e-04 | 9 | 85 | 2 | 8530078 | |
| Pubmed | 2.10e-04 | 9 | 85 | 2 | 30406191 | ||
| Pubmed | The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA. | 2.20e-04 | 349 | 85 | 6 | 25665578 | |
| Pubmed | 2.62e-04 | 10 | 85 | 2 | 19776387 | ||
| Pubmed | COUP-TFs regulate eye development by controlling factors essential for optic vesicle morphogenesis. | 3.20e-04 | 11 | 85 | 2 | 20147377 | |
| Pubmed | Ephrin-A5 and EphA5 interaction induces synaptogenesis during early hippocampal development. | 3.20e-04 | 11 | 85 | 2 | 20824214 | |
| Pubmed | Interaction of Sox2 with RNA binding proteins in mouse embryonic stem cells. | 3.45e-04 | 135 | 85 | 4 | 31077711 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | 3.79e-04 | 908 | 85 | 9 | 19274049 | |
| Pubmed | 3.83e-04 | 12 | 85 | 2 | 15140878 | ||
| Pubmed | 3.83e-04 | 12 | 85 | 2 | 19812316 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q11 | SPDYE11 SPDYE17 SPDYE10 SPDYE13 SPDYE15 SPDYE7P SPDYE8 SPDYE21 SPDYE9 SPDYE5 SPDYE18 SPDYE12 SPDYE14 SPDYE16 | 1.64e-16 | 271 | 87 | 14 | chr7q11 |
| Cytoband | 7q11.23 | 7.68e-10 | 97 | 87 | 7 | 7q11.23 | |
| Cytoband | 7q22.1 | 6.62e-05 | 113 | 87 | 4 | 7q22.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q22 | 8.23e-04 | 219 | 87 | 4 | chr7q22 | |
| Cytoband | 4q32.1 | 1.12e-03 | 26 | 87 | 2 | 4q32.1 | |
| GeneFamily | Speedy/RINGO cell cycle regulator family | SPDYE1 SPDYE7P SPDYE3 SPDYE2 SPDYE8 SPDYE9 SPDYE5 SPDYE2B SPDYE4 SPDYE6 | 2.61e-25 | 12 | 46 | 10 | 756 |
| GeneFamily | Nuclear hormone receptors | 2.62e-04 | 49 | 46 | 3 | 71 | |
| GeneFamily | Synaptotagmins | 8.41e-04 | 17 | 46 | 2 | 765 | |
| Coexpression | GSE30083_SP2_VS_SP3_THYMOCYTE_UP | 2.60e-06 | 199 | 80 | 7 | M5031 | |
| Coexpression | BRUINS_UVC_RESPONSE_LATE | SPDYE1 CCNDBP1 SPDYE7P SPDYE3 SPDYE2 VPS26C HAT1 SPDYE5 SPDYE2B SPDYE4 PCGF5 DKK2 SPDYE6 SPDYE16 SOS1 | 2.95e-06 | 1198 | 80 | 15 | MM1062 |
| Coexpression | GSE37416_0H_VS_3H_F_TULARENSIS_LVS_NEUTROPHIL_DN | 3.16e-05 | 197 | 80 | 6 | M5342 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.60e-07 | 169 | 81 | 6 | 87116c33c5ca8cb1862e103e5607b1df4d264569 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.05e-06 | 183 | 81 | 6 | 4d16bfbadf2cd13008c35e23dd2b5b4ecf92ee11 | |
| ToppCell | COVID-19-lung-Lymphatic_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.39e-06 | 192 | 81 | 6 | cbe57cda44232b183821ac633b60a2668265e616 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.43e-06 | 193 | 81 | 6 | 040f6bb42aa41d0921371fdda1cc0912c4fe1930 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.43e-06 | 193 | 81 | 6 | e468287c8b30c56d1de65e8347ade233ba6cf584 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.48e-06 | 194 | 81 | 6 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.52e-06 | 195 | 81 | 6 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | Parenchymal-10x3prime_v2-Endothelial-Endothelia_lymphatic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.76e-06 | 200 | 81 | 6 | 76e90231aa94afc12e618da8ae314c51644acab4 | |
| ToppCell | Parenchymal-10x3prime_v2-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.76e-06 | 200 | 81 | 6 | e3e80cb16e0d2e24efc16b62316a6da91bf81ea5 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-05 | 172 | 81 | 5 | 073a503dc922e3e3ac3528e249b0f8b74402110b | |
| ToppCell | Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)|Adult / Lineage, Cell type, age group and donor | 1.70e-05 | 175 | 81 | 5 | 4db1a3c284488b3f6de7568363f176d74e2a4587 | |
| ToppCell | Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)-D231|Adult / Lineage, Cell type, age group and donor | 1.70e-05 | 175 | 81 | 5 | 8d9f44a2633b71fb4d2b4a7d9530f954e07c4a18 | |
| ToppCell | COVID-19-Heart-Lymph_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.79e-05 | 177 | 81 | 5 | 326fde0734ef0d7272693966d346ca479b9d8147 | |
| ToppCell | 5'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.79e-05 | 177 | 81 | 5 | b1775e05c28883a15c56628028770bc59d3233fb | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.84e-05 | 178 | 81 | 5 | ad3de3e03a401dac64431a541899445262246347 | |
| ToppCell | COVID-19-Heart-Lymph_EC|Heart / Disease (COVID-19 only), tissue and cell type | 1.89e-05 | 179 | 81 | 5 | 411620201a860716a8773b92f50f7b94ef34a586 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.99e-05 | 181 | 81 | 5 | e898ecb8d8f2eb2204225b7b0d665cadcd241139 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_mature-Lymphatic_EC_mature_L.2.5.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.16e-05 | 184 | 81 | 5 | e5756afa3181186f9b65552b8df5359ef4024bee | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.27e-05 | 186 | 81 | 5 | 40070d9cd20188ba49b32acfca9bc16256b38bf5 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.27e-05 | 186 | 81 | 5 | 20340a5b5cc7f07386498a4ef937d6fbc9e347c4 | |
| ToppCell | COVID-19-lung-Lymphatic_EC|lung / Disease (COVID-19 only), tissue and cell type | 2.45e-05 | 189 | 81 | 5 | c8db9aaf54ea3cc96c4a2f777c3389e0f31f67f3 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_mature|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.65e-05 | 192 | 81 | 5 | 291df12b4b5ff11fbaa43033692b8f4b5cdf65a1 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_mature-Lymphatic_EC_mature_L.2.5.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.65e-05 | 192 | 81 | 5 | 35ffe7aa9ffab85eac3326651e901c39d0119650 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.78e-05 | 194 | 81 | 5 | 85e00861c5068a27d0cf0ae677f420c8245baa9a | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.85e-05 | 195 | 81 | 5 | 8f3b455553215f6e191842a5953a79c606f22c08 | |
| ToppCell | COPD-Endothelial-Lymphatic|Endothelial / Disease state, Lineage and Cell class | 2.85e-05 | 195 | 81 | 5 | e91ce548ae7224661ee5d2f2639794a5f69798ee | |
| ToppCell | IPF-Endothelial-Lymphatic|Endothelial / Disease state, Lineage and Cell class | 2.85e-05 | 195 | 81 | 5 | de88e9d22044b4b3e29676ad02b3e9299cc920ad | |
| ToppCell | 343B-Endothelial_cells-Endothelial-F_(Lymphatics)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.85e-05 | 195 | 81 | 5 | fc75f04eb475c8139cc5c35e6be22e73fb2be9e6 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.85e-05 | 195 | 81 | 5 | 7e71b1707b34ce47fffadf6f64d9554768221fc6 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-F_(Lymphatics)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.85e-05 | 195 | 81 | 5 | 83d45ff5e5bc704448431149fffb2e4c1278f279 | |
| ToppCell | facs-Thymus-Thymus_Epithelium|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.92e-05 | 196 | 81 | 5 | 6bc1187dfc4860a4e09032d7ea87ba3d9fe9f363 | |
| ToppCell | Control-Endothelial-Lymphatic|Endothelial / Disease state, Lineage and Cell class | 2.92e-05 | 196 | 81 | 5 | e0cf617b0f5d9c3c19574f587a3d0ccbf93d8ca4 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.92e-05 | 196 | 81 | 5 | c8c89e469402e11aa2a9561e859b6fd1fb66c39b | |
| ToppCell | 356C-Endothelial_cells-Endothelial-F_(Lymphatics)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.92e-05 | 196 | 81 | 5 | b04ca69b0ed44e09c989b575f747e1e819cd8008 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-F_(Lymphatics)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.92e-05 | 196 | 81 | 5 | a31e227de2dc077b81881295b012d22fedbd65ed | |
| ToppCell | normal_Lung-Endothelial_cells-Lymphatic_ECs|Endothelial_cells / Location, Cell class and cell subclass | 2.99e-05 | 197 | 81 | 5 | c838d0f64e3b43a616a9e381b8139bfe9aa32da7 | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.07e-05 | 198 | 81 | 5 | 9ab0db78394e730f6866b2db80047149024ad5f6 | |
| ToppCell | distal-1-Endothelial-Lymphatic|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.07e-05 | 198 | 81 | 5 | b6fea363463c8dd7e6780c085ece4900266a6286 | |
| ToppCell | LAM-Endothelial-LymEndo|Endothelial / Condition, Lineage and Cell class | 3.07e-05 | 198 | 81 | 5 | ba64b1c95dfaa995045239d412e725596f6c482e | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.07e-05 | 198 | 81 | 5 | e47d0e2c6353315c85d7007742bb16b0f05795ed | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4-Tfh|Lung / Manually curated celltypes from each tissue | 1.05e-04 | 134 | 81 | 4 | da3cb572d0c19932619e51e272c0555e91b482ac | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_VISp_Krt80_Sla|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.66e-04 | 151 | 81 | 4 | f50c5ae9dae507df750df25e151b58685fec70ce | |
| ToppCell | facs-Brain_Myeloid-Cortex_-18m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.88e-04 | 156 | 81 | 4 | 2ba838bc864c2c1767bcab7bb4d790af96b91387 | |
| ToppCell | CD8+_Memory_T_cell-RSV-6|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 1.97e-04 | 158 | 81 | 4 | 5ae737757a49fc96bde1e57e02066f9f65654ea1 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 2.22e-04 | 163 | 81 | 4 | 19c28ce16a588a7f4a035c32726f6ccd67702b5b | |
| ToppCell | COVID-19-kidney-Lymphatic_EC|kidney / Disease (COVID-19 only), tissue and cell type | 2.44e-04 | 167 | 81 | 4 | 97d0fea1f41c1c00e36d9b5c4c1f0dd85087056f | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.61e-04 | 170 | 81 | 4 | 4848965bc7e9356c6601bb41eeea1553d2eea87e | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.91e-04 | 175 | 81 | 4 | c1c722db42da9b8a2a46e516ddb83d9be5e2e504 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.91e-04 | 175 | 81 | 4 | f6e1d7297a4dbb38e1ab4f738d91f0e62abaee69 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.04e-04 | 177 | 81 | 4 | 4553ee8cd9c24db6511b09fe49ed11a89e7cde9e | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G-|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.04e-04 | 177 | 81 | 4 | 7617270f49cd6b7ba66db72d20560cee985012b2 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.04e-04 | 177 | 81 | 4 | 8220cc2fc0ee8764a67a3be51d75248be2453040 | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_C|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.11e-04 | 178 | 81 | 4 | 50bb1f2c6a8d050ff2af217fd76c3b1b7b4a4a69 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.11e-04 | 178 | 81 | 4 | 78a0c6340001a77f5b2d890b6263f574af2e72da | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.17e-04 | 179 | 81 | 4 | dcd0a83f0592ae27f814d064b4791f84c3c86e64 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-ventral_progenitors_and_neurons_2|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 3.17e-04 | 179 | 81 | 4 | d95367d689732ab2653e8d70d8d8e5eb15ae6eef | |
| ToppCell | ILEUM-non-inflamed-(7)_Lymphatics|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.17e-04 | 179 | 81 | 4 | 99777a8931356d1206b8ab22aaa1b1d5a600b809 | |
| ToppCell | ASK454-Endothelial-Lymphatic|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.17e-04 | 179 | 81 | 4 | fd84a79f76a01c0377dff5b20016b004d369f96f | |
| ToppCell | 5'-Adult-Appendix-Endothelial-lymphatic_endothelial-LEC6_(ADAMTS4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.38e-04 | 182 | 81 | 4 | fd786c88826ad3d5cc5c3d80f8e392d6be1b5267 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.38e-04 | 182 | 81 | 4 | 53c267ee327e116dbd89d5927ed3bdf78d25ee62 | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.45e-04 | 183 | 81 | 4 | f55081068213cc1cdb2acad58ff10f6b48b44c72 | |
| ToppCell | 5'-Adult-Appendix-Endothelial-lymphatic_endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.52e-04 | 184 | 81 | 4 | 453295362888c9a59d0e73c7a5b15914c50ff591 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.52e-04 | 184 | 81 | 4 | 1c857126c0ea0671f0d60b048efca288d348d653 | |
| ToppCell | COVID-19-Neuronal_cells|COVID-19 / group, cell type (main and fine annotations) | 3.60e-04 | 185 | 81 | 4 | 36ce23893915f5c380cca39b2c33a516edf31c3a | |
| ToppCell | Endothelial-B-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 3.60e-04 | 185 | 81 | 4 | 133c9dc64d564dae4aeeeca22f386aa3f13fa980 | |
| ToppCell | COVID-19-Neuronal_cells-Neuronal_cells|COVID-19 / group, cell type (main and fine annotations) | 3.60e-04 | 185 | 81 | 4 | 4a095829992b39856a73bdfac03ee68b9aa0d3b8 | |
| ToppCell | ILEUM-inflamed-(7)_Lymphatics|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.60e-04 | 185 | 81 | 4 | d711dd2e91cfee723dae1ccb2b910b8cf3becc3b | |
| ToppCell | 343B-Endothelial_cells-Endothelial-F_(Lymphatics)|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.67e-04 | 186 | 81 | 4 | 7a8da2ad140bea3207bd868212cc5e201d586772 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-F_(Lymphatics)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.67e-04 | 186 | 81 | 4 | dc394034929c6b10ae0e1c1a028cc3d4ce873298 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)|World / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.67e-04 | 186 | 81 | 4 | 32af3f211f9ad5d5c6b86b83325cfbf2f8466b56 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_MOBP_COL18A1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.67e-04 | 186 | 81 | 4 | d57c40b3fe5cfc87e771df76533d9a3e94678b04 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 3.75e-04 | 187 | 81 | 4 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.75e-04 | 187 | 81 | 4 | 65d406122dffe18279f14a1ed35ba091730b97be | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.75e-04 | 187 | 81 | 4 | 4c15c0ed41a55271fc793cb76fee97fa64190369 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.75e-04 | 187 | 81 | 4 | 5274f2b302bbf7fed30c480af4f35058d2cf61e0 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D175|Adult / Lineage, Cell type, age group and donor | 3.75e-04 | 187 | 81 | 4 | 1e52d3d9d664c813d859b5b75e4c07b218818f95 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-F_(Lymphatics)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 3.82e-04 | 188 | 81 | 4 | 1f40b959777d18ad88d239df8cca304f062ba04c | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.82e-04 | 188 | 81 | 4 | 26915db8863f4115b46a81982e187322e21600fd | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.82e-04 | 188 | 81 | 4 | 3f76c0f912f8f023ea425be7f43593b3d7f967e3 | |
| ToppCell | ASK428-Endothelial-Lymphatic|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.82e-04 | 188 | 81 | 4 | c371bc340966cfe9205cbf4b62c6452f49f2559f | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.82e-04 | 188 | 81 | 4 | 61ee7b152745164293d8a44ef91ee2393efbdca5 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.82e-04 | 188 | 81 | 4 | 2db80767903703e7e0a1a37c598f7877a909ee94 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.82e-04 | 188 | 81 | 4 | c2805232618a7b6f844d34e37ad458a9923dbfe1 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-F_(Lymphatics)|390C / Donor, Lineage, Cell class and subclass (all cells) | 3.82e-04 | 188 | 81 | 4 | aa69e3f44d506f5ef358a3374ac5160d847c858f | |
| ToppCell | E17.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.90e-04 | 189 | 81 | 4 | 26cfe5b7e7f477f225f4e9f25f983f432f01e183 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Neuronal-Neuron|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 3.90e-04 | 189 | 81 | 4 | 3717d1148e26ac78a26aea0ca1dbfbb9d3668877 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.98e-04 | 190 | 81 | 4 | 876bd2eb9ed2624cb23bdcf6b989e4fa34d099e3 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel|Adult / Lineage, Cell type, age group and donor | 3.98e-04 | 190 | 81 | 4 | 91bf3b7e9148589757436a53a4f58e0ebfe54400 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Endothelial-Lymphatic|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.98e-04 | 190 | 81 | 4 | 8d6ec2fc0af19a5cb16fff34f8b131b71b33d45f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.98e-04 | 190 | 81 | 4 | be9f36127028f52ca5fc1b32ba15a6c26aad69ac | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.98e-04 | 190 | 81 | 4 | 09a8855901c3c9332dbaab3e40166485b696d0f1 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Neuronal-Immature_INs|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 3.98e-04 | 190 | 81 | 4 | 842760bfe0a52e67bad800efa7d99448a4a23ebb | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.06e-04 | 191 | 81 | 4 | 361b123c8289015206d5e706ab2c615d9a724179 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Endothelial-lymphatic_endothelial|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.06e-04 | 191 | 81 | 4 | 011dc22c488369734749e839d65d52fe46b6a1a4 | |
| ToppCell | P07-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.06e-04 | 191 | 81 | 4 | 2ad717b59215ad8d933e9637d363b65d7298e5d4 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-F_(Lymphatics)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.14e-04 | 192 | 81 | 4 | 5f4f44f15d3a2846981e68296643a4634930a211 | |
| ToppCell | IPF-Endothelial-Lymphatic|IPF / Disease state, Lineage and Cell class | 4.14e-04 | 192 | 81 | 4 | 2496edd8f3a41146d418879de9ee2ccc7857431f | |
| ToppCell | 367C-Endothelial_cells-Endothelial-F_(Lymphatics)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.14e-04 | 192 | 81 | 4 | 5e709c0714e8eba27e03a6def0544256bedb3ced | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.14e-04 | 192 | 81 | 4 | 26d9207e72bbef5e0046de511e2c9ff752b726f3 | |
| ToppCell | COPD-Endothelial-Lymphatic|World / Disease state, Lineage and Cell class | 4.22e-04 | 193 | 81 | 4 | 25bdc557055b5bce6a21f8696b48e991c696b979 | |
| Drug | Fluspirilen [1841-19-6]; Down 200; 8.4uM; HL60; HT_HG-U133A | 4.55e-06 | 196 | 77 | 7 | 3086_DN | |
| Disease | Arts syndrome (implicated_via_orthology) | 5.87e-06 | 2 | 72 | 2 | DOID:0050647 (implicated_via_orthology) | |
| Disease | X-linked nonsyndromic deafness (implicated_via_orthology) | 5.87e-06 | 2 | 72 | 2 | DOID:0050566 (implicated_via_orthology) | |
| Disease | Charcot-Marie-Tooth disease X-linked recessive 5 (implicated_via_orthology) | 1.76e-05 | 3 | 72 | 2 | DOID:0110210 (implicated_via_orthology) | |
| Disease | Clear Cell Sarcoma of Soft Tissue | 3.51e-05 | 4 | 72 | 2 | C0206651 | |
| Disease | Morphine Abuse | 1.22e-04 | 7 | 72 | 2 | C0600272 | |
| Disease | Morphine Dependence | 1.22e-04 | 7 | 72 | 2 | C0026552 | |
| Disease | Noonan syndrome | 2.09e-04 | 9 | 72 | 2 | cv:C0028326 | |
| Disease | Turner Syndrome, Male | 3.18e-04 | 11 | 72 | 2 | C0041409 | |
| Disease | Female Pseudo-Turner Syndrome | 3.18e-04 | 11 | 72 | 2 | C1527404 | |
| Disease | Noonan Syndrome 1 | 3.18e-04 | 11 | 72 | 2 | C4551602 | |
| Disease | ankle injury | 4.11e-04 | 59 | 72 | 3 | EFO_1002021 | |
| Disease | RASopathy | 6.04e-04 | 15 | 72 | 2 | cv:C5555857 | |
| Disease | response to ketamine | 6.50e-04 | 69 | 72 | 3 | EFO_0009748 | |
| Disease | estrogen-receptor negative breast cancer | 7.07e-04 | 71 | 72 | 3 | EFO_1000650 | |
| Disease | Noonan-Like Syndrome With Loose Anagen Hair | 9.77e-04 | 19 | 72 | 2 | C3501846 | |
| Disease | Costello syndrome (disorder) | 9.77e-04 | 19 | 72 | 2 | C0587248 | |
| Disease | Noonan syndrome-like disorder with loose anagen hair | 9.77e-04 | 19 | 72 | 2 | C1843181 | |
| Disease | Cardio-facio-cutaneous syndrome | 9.77e-04 | 19 | 72 | 2 | C1275081 | |
| Disease | alpha-tocopherol measurement | 1.08e-03 | 20 | 72 | 2 | EFO_0007898 | |
| Disease | LEOPARD Syndrome | 1.31e-03 | 22 | 72 | 2 | C0175704 | |
| Disease | Noonan Syndrome | 1.57e-03 | 24 | 72 | 2 | C0028326 | |
| Disease | type 2 diabetes mellitus (implicated_via_orthology) | 2.19e-03 | 105 | 72 | 3 | DOID:9352 (implicated_via_orthology) | |
| Disease | free androgen index | 2.22e-03 | 374 | 72 | 5 | EFO_0007005 | |
| Disease | executive function measurement | 2.28e-03 | 376 | 72 | 5 | EFO_0009332 | |
| Disease | lung carcinoma, family history of lung cancer | 2.28e-03 | 29 | 72 | 2 | EFO_0001071, EFO_0006953 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NAVKKRLMTDRRIGC | 241 | P08243 | |
| RLMAECLKKKRDERP | 691 | P15056 | |
| RAALGRMCTVIKRQK | 131 | Q9BZE4 | |
| MVCRRKKKRCHRDGM | 101 | Q9UBU2 | |
| KGKMRRIDCLRQADK | 111 | Q12857 | |
| CKMDLGRTRRISFKG | 386 | O95294 | |
| RLLLGNKCDMEAKRK | 116 | P51153 | |
| GVRIKECRVMRDLKG | 516 | Q9NW13 | |
| CRLKKCFRVGMRKEA | 111 | P10588 | |
| CRLKKCLKVGMRREA | 141 | P10589 | |
| LKKCLKVGMRREAVQ | 136 | P24468 | |
| RRKDCDKEKRVKLMS | 146 | Q15397 | |
| CKAETLMQARKRKRT | 221 | Q06416 | |
| KMRCLRKRSTVSFLG | 16 | Q9UBM8 | |
| VVKGLMKKFIRCSTR | 156 | Q86SE9 | |
| KSRLRKMKSCLEFSL | 186 | Q7L5Y9 | |
| MAGCTRKLTHLRKRI | 1 | Q8NCT3 | |
| KKKGLLRLARKGSMR | 31 | Q8N8Q9 | |
| RMKKCLKGISSRISG | 636 | A8MYU2 | |
| DFKEAVRKVMRRKCG | 296 | Q8NGX0 | |
| RGEIACRVIRTCKKM | 71 | P05165 | |
| RNKEVKGALRKAMTC | 291 | Q8NH79 | |
| LFRVNMSEKKRCKRI | 106 | Q86XN7 | |
| MCKKTRDLRRQLRKA | 366 | Q9UI47 | |
| DIKRGKRKRLSSVMC | 176 | Q8N4S0 | |
| KQRDLAKMRKCLRPE | 366 | O14929 | |
| MTKRKKLRTSGEGLC | 1 | Q0VDD7 | |
| MELKEGKKHTCGLRR | 306 | Q9H7D0 | |
| ALVRASKACLKKIRM | 246 | O95273 | |
| RLKSAIEKAMISCRK | 346 | Q9P278 | |
| GEMSEKLRRCRKELT | 11 | Q6ZUJ4 | |
| EACGMRRKSLLTRKV | 106 | Q9H4A6 | |
| LMKNREAARECRRKK | 276 | P16220 | |
| KMRKRGSIVCKLLAS | 106 | Q14558 | |
| QCKMRKRGSIVSKLL | 116 | O60256 | |
| HRMLAVRKLKKGGRC | 1031 | Q6ZMW3 | |
| KSRSESKRMKGFCLI | 831 | P42261 | |
| PKSKRQKKERMLLCR | 66 | Q14839 | |
| CLRQRMERRLKGSLK | 571 | Q8IX30 | |
| LRKMLRKEAAARCVV | 11 | Q16690 | |
| LMCDGRRLKKRKTST | 396 | Q86SS6 | |
| LCHLRKKQGAARAKM | 536 | P07204 | |
| MCKILKDSDLLDRRK | 341 | Q9NSN8 | |
| AETLCGLKMKAKRRR | 86 | P0DUX0 | |
| AETLCGLKMKAKRRR | 86 | P0DTA3 | |
| AETLCGLKMKAKRRR | 86 | P0DUD1 | |
| CDKCRGMSRGKVIRL | 106 | Q9C0A6 | |
| CNMKKSRLGRSRAVR | 31 | Q06250 | |
| LVSEAIKVLMGKCRR | 321 | O15160 | |
| GKRKRLFSKELRCMM | 26 | Q15543 | |
| GMEKICSKSLAKRRL | 386 | Q07889 | |
| LCGLKMKLKRRRVSL | 176 | A6NHP3 | |
| LAKGERLMRCKISSV | 126 | P35612 | |
| MKNREAARECRRKKK | 221 | P18846 | |
| CKIRLHMGDLRKKVA | 121 | Q8N5U0 | |
| ACAAKAKRRLMTLTK | 376 | Q9Y4G8 | |
| MRLKRACIRKAKISA | 81 | Q9C0D3 | |
| KKRKTRGRCEVVIME | 411 | Q9H2G4 | |
| KSLKAKMNRRACLGS | 591 | Q9Y6Q2 | |
| AETLCGLKMKAKRRR | 86 | P0DUX1 | |
| AETLCGLKMKAKRRR | 86 | A0A494C0Z2 | |
| AETLCGLKMKAKRRR | 86 | P0DUD3 | |
| AETLCGLKMKAKRRR | 86 | P0DUD4 | |
| LCGLKMKLKRRRVSL | 136 | A6NNV3 | |
| AETLCGLKMKAKRRR | 86 | P0DUD2 | |
| LCGLKMKLKRRRVSL | 176 | P0DV79 | |
| LCGLKMKLKRRRVLL | 176 | A0A494C086 | |
| LCGLKMKLKRRRVSL | 176 | Q495Y8 | |
| LCGLKMKAKRRRVSL | 81 | A6NKU9 | |
| AETLCGLKMKAKRRR | 151 | A6NKU9 | |
| TLCGLKMKAKRRRVS | 226 | A6NKU9 | |
| VAETLCGLKMKAKRR | 296 | A6NKU9 | |
| CGLKMKAKRRRVSLV | 301 | A6NKU9 | |
| ETLCGLKMKAKRRRV | 371 | A6NKU9 | |
| LCGLKMKLKRKRASS | 86 | A6NLX3 | |
| LCGLKMKLKRRRVSL | 176 | A6NIY4 | |
| LCGLKMKLKRRRVSL | 176 | P0CI01 | |
| MLCGLKMKLKRRRVS | 31 | Q495Y7 | |
| CGLKMKLKRRRVSLV | 136 | Q8NFV5 | |
| LRIERCMLTREIKKG | 1681 | Q9H5I5 | |
| KMKLRECLNIRKSLF | 966 | Q6P2S7 | |
| KRRLAMCARKLGRIR | 296 | Q8TDW4 | |
| MCARKLGRIREAVKI | 301 | Q8TDW4 | |
| SLMCEGRRLKKRKTT | 406 | Q6XYQ8 | |
| IMRLSGRCRKKREGD | 1121 | Q7Z4N2 | |
| MLCDEKAQKRRKRKA | 1 | Q8WV37 | |
| LREKLSKCDMRGKEF | 191 | Q9UIE0 | |
| LCGLKMKLKRRRVSL | 136 | A6NJR5 | |
| AETLCGLKMKAKRRR | 86 | A0A494C191 | |
| RKNKMSLALKNIRCR | 601 | Q8ND82 | |
| LEKEIASLRRKMKTC | 141 | Q9H0W7 | |
| ASLRRKMKTCLQKER | 146 | Q9H0W7 | |
| RKRKRKAKESGMALL | 56 | Q9NV72 | |
| KCRITRDKKGMDRGM | 266 | P50607 | |
| RCDMKRSLLAKDLTK | 121 | O14972 | |
| RSEKRARKAMSKLGL | 71 | Q9H009 |